Xcout IntelPluto Biosciences, Inc.
Pluto Biosciences, Inc. is a biotechnology company headquartered in Denver, Colorado, that offers a multi-omics platform for translational scientific discovery.
Subscribe to see Pluto Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pluto Biosciences, Inc. at a glance
Pluto Biosciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $7.7M across the 3 funding rounds on record. Its most recent funding round raised $3M in April 2025. Xcout tracks 11 named people at Pluto Biosciences, Inc., including Rani K. Powers (CEO).
Pluto Biosciences, Inc. leadership
- Rani K. PowersCEO
- Mark SwendsenChief Revenue Officer
- Donald E. IngberFounding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Translational Medicine Pioneer
- Irene MorgansternDirector of Preclinical Initiatives, Neuroscientist
- Rani K. PowersExecutive Officer
- Christopher GlodeDirector
5 more named people on record for Pluto Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Pluto Biosciences, Inc. funding rounds
At least $7.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $3.7M | — | |
| Seed | $1M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Pluto Biosciences, Inc. competitors
A few of Pluto Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nautilus Biotechnology, Inc. is a development stage life sciences company focused on creating a platform technology designed to quantify and unlock the complexity of the proteome.
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Origin Bio operates a tissue-first data and model platform that maps cancer biology using patient tumor samples. The company generates spatial, molecular, and functional maps from real tumor tissue to support target discovery, drug response prediction, and multimodal AI modeling for researchers and life sciences partners.
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Volastra Therapeutics, Inc. is a U.S. biotechnology company developing cancer medicines designed to prevent or treat metastasis, the spread of tumors to other parts of the body. It uses functional genomics and related technologies to discover therapeutic targets and serves the oncology and biopharmaceutical markets.
Get Pluto Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pluto Biosciences, Inc. in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access